SCHEMBL904033

SCHEMBL904033

Nc1nc(C(=O)N2Cc3ccccc3C2)c2cc(-c3ccccc3CN3CCC(N)C3)ccc2n1

nearest known ligand 0.70

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 11/20 0.70
HSP90AB1 P08238 3/20 0.54
F10 P00742 2/20 0.40
DHODH Q02127 1/20 0.39
HRH4 Q9H3N8 1/20 0.36
CCNT1 O60563 1/20 0.35
CDK9 P50750 1/20 0.35
CCR2 P41597 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
SCN9A Q15858 1/20 0.34
ADORA2A P29274 1/20 0.34
ADORA1 P30542 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15091206 0.93 HSP90AA1 (0.70) HSP90AA1HSP90AB1F10DHODHCCR2
SCHEMBL904222 0.93 HSP90AA1 (0.70) HSP90AA1HSP90AB1F10DHODHCCR2
SCHEMBL904024 0.93 HSP90AA1 (0.70) HSP90AA1HSP90AB1F10DHODHCCR2
SCHEMBL904224 0.92 HSP90AA1 (0.70) HSP90AA1HSP90AB1F10
SCHEMBL10256450 0.90 HSP90AA1 (0.71) HSP90AA1HSP90AB1F10DHODH
SCHEMBL904155 0.90 HSP90AA1 (0.73) HSP90AA1HSP90AB1F10ADORA2AADORA1
SCHEMBL904058 0.88 HSP90AA1 (0.81) HSP90AA1HSP90AB1F10DHODHADORA2A
SCHEMBL3093432 0.86 HSP90AA1 (0.75) HSP90AA1HSP90AB1F10HRH4ADORA2A
SCHEMBL13144877 0.85 HSP90AA1 (0.74) HSP90AA1HSP90AB1DHODHADORA2AADORA1
SCHEMBL3080612 0.85 HSP90AA1 (0.74) HSP90AA1HSP90AB1F10DHODHADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-8791129-B2 Phenylquinazoline derivatives MERCK PATENT GMBH (DE) 2014-07-29 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2013-07-11 US disclosed
WO-2012041435-A1 PHENYLQUINAZOLINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-04-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130178443-A1 PHENYLQUINAZOLINE DERIVATIVES HSP90B1, HSP90AB1, HSP90AA1 HSP90AA1 3/4885HSP90AB1 2/4885F10 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.